Trademark: 76434604
Status Date
Tuesday, August 19, 2014
Registration Number
2868416
Registration Date
Tuesday, August 3, 2004
Filing Date
Thursday, July 25, 2002
Published for Opposition
Tuesday, May 11, 2004
40 [ Custom synthesis of chemicals used in industry and science for third parties; custom immobilization of arrays of chemicals compounds for others, custom modification of peptides and proteins for others and custom transformation of chemical compounds for others]
9 [ Scientific measuring and checking apparatus and instruments, namely, micro-array scanner comprised of filters and cellulose or polypropylene membranes for use in the field of biotechnology, pharmacology and for use in pharmaceutical research; analytical device, namely, robot, synthesizer, spotter and nanoplotter for non-medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]
5 [ Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely, cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins, and peptidomimetics; ] carrier materials comprised of [ nucleic acids, ] peptides and proteins for diagnostic purposes for medical treatments
1 [ Chemicals for use in the manufacture of pharmaceuticals; ] carrier materials comprised of [ nucleic acids, ] peptides and proteins for research purposes, for pharmaceutical research, for diagnostic purposes for scientific research, for biochemical research purposes in the field of antibody epitope mapping, proteine/proteine interaction, and enzyme profiling
44 [ Human and veterinary medical services; pharmaceutical advice; physician services; veterinary services ]
10 [ Analytical device, namely, nanoplotter for medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]
42 [ Scientific research, namely, immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely, development of new technology for others; design and development of new technology for others in the field of biotechnology and pharmaceuticals; industrial analysis and research services in the field of biotechnology and pharmaceuticals, namely, synthesis and immobilization of chemicals used in industry and science, screening for interaction partners, antibody epitope mapping, proteine/proteine interaction, and enzyme profiling; design and development of computer hardware and software; scientific research in the field of synthesis and immobilization of chemicals use in industry and science; chemical research, namely, screening for chemical interactions of enzymes, enzyme substrates, antigens and antibodies; development of inhibitors of receptors and enzymes, namely, kinases, oxydoreductases, transerases, hydrolases, lyases, isomerases, and ligases; research and development of diagnostic assays, assays for pharmaceutical drug discovery and assays for target validation, namely, methods for antigene detection and enzyme substrate identification for others; product research and development of chemicals used in industry and science; computer programming for other for the herein aforementioned purposes; agricultural research; scientific research; industrial design; computer programming for others; chemist, biologist, biochemist, biotechnologist, gene technologist, molecular biologist, pharmacology, and physicist services ]
In the statement, Column 1, line 15 through 26, " Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins, and peptidomimetics; carrier materials comprised of nucleic acids, peptides and proteins for diagnostic purposes for medical treatments" is deleted, and Carrier materials comprised of peptides and proteins for diagnostic purposes for medical treatments is re-inserted.
PEP STAR
Sep 27, 2023
Teas Change Of Correspondence Received
Sep 27, 2023
Teas Change Of Domestic Representatives Address
Sep 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 27, 2023
Teas Change Of Owner Address Received
Aug 3, 2023
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Oct 7, 2022
Teas Change Of Correspondence Received
Oct 7, 2022
Teas Change Of Domestic Representatives Address
Oct 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 22, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 22, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 31, 2018
Teas Change Of Correspondence Received
Mar 17, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 17, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 19, 2014
Notice Of Acceptance Of Sec. 8 - E-Mailed
Aug 19, 2014
Registered And Renewed (First Renewal - 10 Yrs)
Aug 19, 2014
Registered - Sec. 9 Granted/Check Record For Sec. 8
Aug 19, 2014
Registered - Partial Sec. 8 (10-Yr) Accepted
Aug 19, 2014
Case Assigned To Post Registration Paralegal
Jul 31, 2014
Teas Section 8 & 9 Received
Dec 22, 2011
Teas Change Of Correspondence Received
Aug 9, 2010
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Aug 6, 2010
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Aug 9, 2010
Amendment Under Section 7 ¿ Processed
Aug 6, 2010
Sec 7 Request Filed
Aug 6, 2010
Teas Response To Office Action-Post Reg Received
Aug 4, 2010
Post Registration Action Mailed - Sec. 7
Aug 3, 2010
Case Assigned To Post Registration Paralegal
Aug 2, 2010
Teas Section 7 Request Received
Jul 30, 2010
Teas Section 8 & 15 Received
May 12, 2010
Automatic Update Of Assignment Of Ownership
Mar 9, 2010
Teas Change Of Correspondence Received
Oct 24, 2007
Review Of Correspondence Complete
Oct 18, 2007
Paper Received
Aug 4, 2004
Exparte Appeal Terminated
Aug 3, 2004
Registered-Principal Register
Jun 18, 2004
Paper Received
May 11, 2004
Published For Opposition
Apr 21, 2004
Notice Of Publication
Feb 20, 2004
Approved For Pub - Principal Register
Feb 20, 2003
Correspondence Received In Law Office
Feb 19, 2003
Correspondence Received In Law Office
Jan 28, 2004
Case File In Ticrs
Jan 23, 2004
Jurisdiction Restored To Examining Attorney
Jan 23, 2004
Ex Parte Appeal-Instituted
Jan 9, 2004
Exparte Appeal Received At Ttab
Jul 9, 2003
Final Refusal Mailed
May 6, 2003
Sec. 1(B) Claim Deleted
May 6, 2003
Correspondence Received In Law Office
May 6, 2003
Paper Received
Jan 3, 2003
Assigned To Examiner
Nov 8, 2002
Non-Final Action Mailed
Nov 7, 2002
Paper Received
Nov 5, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
